Company Filing History:
Years Active: 1984
Title: The Innovations of Katsuhiko Shuto
Introduction
Katsuhiko Shuto is a notable inventor based in Takatsuki, Japan. He has made significant contributions to the field of pharmacology, particularly in the development of compositions that stabilize PGI.sub.2 analogs. His work is crucial for advancing treatments for various cardiovascular conditions.
Latest Patents
Katsuhiko Shuto holds a patent for a composition containing PGI.sub.2 analogs stabilized. This innovative composition includes a PGI.sub.2 analogue in solution with a solvent that consists of at least one pharmacologically acceptable alcohol, polar aprotic solvent, or medium-chain triglyceride. The patent also covers cyclodextrin clathrates of a PGI.sub.2 analogue, which help stabilize the analogues against decomposition. These compositions are particularly useful in treating arteriosclerosis, cardiac failure, or thrombosis.
Career Highlights
Shuto is associated with Ono Pharmaceutical Co., Ltd., where he has been instrumental in research and development. His work has led to advancements in pharmaceutical formulations that enhance the efficacy of treatments for serious health conditions.
Collaborations
Katsuhiko Shuto has collaborated with esteemed colleagues, including Masaki Hayashi and Yoshitsugu Iijima. Their combined expertise has contributed to the success of various projects within the pharmaceutical industry.
Conclusion
Katsuhiko Shuto's innovative work in stabilizing PGI.sub.2 analogs represents a significant advancement in medical treatments for cardiovascular diseases. His contributions continue to impact the field positively.